The enhancement of thermal-neutron induced cell death by 10-boron dextran
Ujeno, Y.; Akaboshi, M.; Maki, H.; Kawai, K.; Kanda, K.; Kobayashi, T.; Ono, K.; Kitaoka, Y.; Abraham, R.; Gabel, D.
Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft . 165(2-3): 201-203
1989
ISSN/ISBN: 0179-7158 PMID: 2467389 Document Number: 347314
Document emailed within 1 workday
Related Documents
Takagaki, M.; Ono, K.; Oda, Y.; Kikuchi, H.; Nemoto, H.; Iwamoto, S.; Cai, J.; Yamamoto, Y. 1996: Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors Cancer Research 56(9): 2017-2020Laster, B.H.; Kahl, S.B.; Popenoe, E.A.; Pate, D.W.; Fairchild, R.G. 1991: Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture Cancer Research 51(17): 4588-4593
Wambersie, A.; Menzel, H.G. 1993: RBE in fast neutron therapy and in boron neutron capture therapy. a useful concept or a misuse? Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 169(1): 57-64
Gahbauer, R.; Kanellitsas, C.; Blue, T.; Wang, C.; Clendenon, N.; Fairchild, R.; Laster, B.; McGregor, J.; Goodman, J. 1989: Dose bracketing in boron neutron capture therapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 229-230
Hatanaka, H.; Amano, K.; Sano, K.; Mogami, H.; Hayakawa, T. 1974: Boron-10-slow neutron capture therapy for brain tumors No Shinkei Geka. Neurological Surgery 2(1): 7-16
Hatanaka, H.; Sano, K.; Yasukochi, H. 1988: Boron-neutron capture therapy in brain tumors and other cancers--a radiosurgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt: 2-2): 1115-1123
Hassanzadeh, M.; Chapman, I.V. 1983: Thermal enhancement of bleomycin-induced tumour growth delay: the effect of dose fractionation European Journal of Cancer and Clinical Oncology 19(11): 1517-1519
Matsumura, A.; Zhang, T.; Nakai, K.; Endo, K.; Kumada, H.; Yamamoto, T.; Yoshida, F.; Sakurai, Y.; Yamamoto, K.; Nose, T. 2005: Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study Journal of Experimental and Clinical Cancer Research: Cr 24(1): 93-98
Miyakoshi, J.; Heki, S. 1983: Enhancement of thermal cell killing by methylglyoxal bis(guanylhydrazone) in Chinese hamster V-79 cells Gan 74(2): 226-231
Volkova, O.Y.; Mechetina, L.V.; Taranin, A.V.; Zaboronok, A.A.; Nakai, K.; Lezhnin, S.I.; Frolov, S.A.; Kasatov, D.A.; Lezhnin, S.I.; Frolov, S.A.; Kasatov, D.A.; Makarov, A.N.; Sorokin, I.N.; Sycheva, T.V.; Shchudlo, I.M.; Taskaev, S.Y. 2016: Impact of neutron radiation on the viability of tumor cells cultured in the presence of boron-10 isotope Vestnik Rentgenologii i Radiologii 97(5): 283-288
Mill, A.J. 1989: Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 193-196
Dorn, R.V.; Spickard, J.H.; Griebenow, M.L. 1989: A proposed protocol for clinical trials of boron neutron capture therapy in glioblastoma multiforme Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 233-234
Yong, J.H.; Barth, R.F.; Wyzlic, I.M.; Soloway, A.H.; Rotaru, J.H. 1995: In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy Anticancer Research 15(5b): 2033-2038
Al-Samarrai, S.F.; Takeuchi, A.; Hatanaka, H. 1975: Electron microscopic study on the response of the normal canine brain to boron-neutron capture therapy Gan 66(6): 663-672
Wambersie, A.; Scalliet, P. 1989: Clinical implementation in BNCT (boron neutron capture therapy): fractionated versus protracted low dose rate irradiation Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(5): 407-411
Montagno, E.d.A.; Moreira Filho, L.; Hatanaka, H. 1989: Three cases of terminal stage malignant gliomas in which the diffusely disseminated intraventricular tumors became the target of boron neutron capture therapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 238-240
Matalka, K.Z.; Bailey, M.Q.; Barth, R.F.; Staubus, A.E.; Soloway, A.H.; Moeschberger, M.L.; Coderre, J.A.; Rofstad, E.K. 1993: Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent Cancer Research 53(14): 3308-3313
Bhuiyan, S.I.; Ahmed, F.U.; Mollah, A.S.; Rahman, M.A. 1989: Studies of the neutron transport and shielding properties of locally developed shielding material: poly-boron Health Physics 57(5): 819-824
Kodíćek, M.; Marík, T.; Brabec, V.; Vodráźka, Z. 1981: Thermal denaturation of peripheral red cell membrane proteins in relation to heat-induced cell alterations Acta Biologica et Medica Germanica 40(4-5): 369-371
Takekawa, F.; Nagumo, T.; Shintani, S.; Hashimoto, K.; Kikuchi, H.; Katayama, T.; Ishihara, M.; Amano, O.; Kawase, M.; Sakagami, H. 2007: Tumor-specific cytotoxic activity and type of cell death induced by 4-trifluoromethylimidazoles in human oral squamous cell carcinoma cell lines Anticancer Research 27(6b): 4065-4069